We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 86 start-ups with an aggregate funding of $5.2b. The average funding per company in this subset is $75.5m.
Last update to the database: Feb 18, 2025. See changelog.
PathAI is a Boston-based artificial intelligence company developing therapeutics and healthcare products.
5
Funding Rounds
$390.0m
Money raised
Insilico Medicine is a drug discovery, artificial intelligence company that looks to treat cancer and age related diseases
6
Funding Rounds
$356.3m
Money raised
Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.
10
Funding Rounds
$930.0m
Money raised
Notable Labs is a company providing personalized drug combination testing service for cancer patients.
8
Funding Rounds
$71.3m
Money raised
Inato matches the right sites to the right clinical research study, globally.
4
Funding Rounds
$49.6m
Money raised
Trials.ai is an artificial intelligence company founded by Kim Walpole and Tom Walpole.
4
Funding Rounds
AiCure is an advanced data analytics company that uses artificial intelligence to understand how patients respond to treatments.
4
Funding Rounds
$76.3m
Money raised
Massive Bio is a New York-based company founded by Selin Kurnaz, Dr. Arturo Loaiza-Bonilla and Cagatay M. Culcuoglu, offering precision oncology services to cancer patients, providers, and pharmaceutical companies.
6
Funding Rounds
$15.8m
Money raised
Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.
9
Funding Rounds
$82.6m
Money raised
A company developing anti-aging treatments using components derived from human blood.
3
Funding Rounds
$41.0m
Money raised
OrphAI Therapeutics is a biotechnology research company based in Guilford, Connecticut that develops precision therapeutics technology designed to treat cancer and rare diseases.
2
Funding Rounds
$98.0m
Money raised
ApexQubit is a biotechnology company that is harnessing a proprietary technology for discovery of new medicines to treat patients with undruggable diseases.
3
Funding Rounds
$54.1k
Money raised
Chronicled is a blockchain company founded by Ryan Orr, Samantha Radocchia, Maurizio Greco and David Aho.
10
Funding Rounds
$36.3m
Money raised
Develops medicines for patients suffering from Alzheimer's disease and other neurological disorders.
8
Funding Rounds
$92.7m
Money raised
Deep Lens is an Artificial Intelligence company matching patients with clinical trials.
3
Funding Rounds
$31.2m
Money raised
Athelas is a company developing blood testing device that utilizes deep learning and computer vision.
5
Funding Rounds
$155.6m
Money raised
Deep 6 AI is an artificial Intelligence company founded by Wout Brusselaers.
3
Funding Rounds
$34.0m
Money raised
Ichor Therapeutics is a pre-clinical contract research on aging mechanisms company founded in 2013 by Kelsey Moody.
5
Funding Rounds
$2.5m
Money raised
Mendel.ai is a life science company offering an artificial intelligence platform to aid clinical experts improve their clinical cancer research.
7
Funding Rounds
$65.4m
Money raised
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
4
Funding Rounds
$7.1m
Money raised
Biofourmis is a global health IT start-up in Massachusetts that focuses on personalized care and therapies using digital therapeutics.
7
Funding Rounds
$443.5m
Money raised
Reverie Labs is a drug dicovery company that uses machine learning founded by Jonah Kallenbach.
2
Funding Rounds
$25.0m
Money raised
A biopharmaceutical company developing therapeutics for treating age-related diseases.
3
Funding Rounds
$105.0m
Money raised
An artificial intelligence company with a platform to be used the drug discovery process. It was founded in 2017 and is located in New York City.
1
Funding Rounds
$12.0m
Money raised
PostEra is a biotechnology company that uses machine learning for medicinal chemistry services.
3
Funding Rounds
$26.5m
Money raised
NetraMark is a Toronto-based machine learning software company founded by Joseph Geraci in 2015.
1
Funding Rounds
Anviro Therapeutics is a biotechnology company developing broad spectrum antiviral therapies.
1
Funding Rounds
$650.0k
Money raised
Healx is a biotechnology therapeutics company for rare diseases founded in 2014 by Tim Guilliams.
4
Funding Rounds
$124.1m
Money raised
Medable's offers a healthcare application that provides patient-generated data for researchers, health startups, pharmaceuticals and universities.
7
Funding Rounds
$506.6m
Money raised
Precision therapeutics company developing epigenetic therapies that target arginine methylation in cancer.
2
Funding Rounds
$2.6m
Money raised
SEngine Precision Medicine is a precision medicine company founded by Brady Bernard, Carla Grandori, Christopher Kemp, and VK Gadi.
2
Funding Rounds
$8.1m
Money raised
Arrakis is developing RNA-targeted small molecule (rSM) therapies to millions of patients.
4
Funding Rounds
$226.0m
Money raised
X-37 is a South San Francisco, California-based drug discovery company.
1
Funding Rounds
$14.5m
Money raised
Mekonos is a company that creates cell-engineering platforms
3
Funding Rounds
$31.0m
Money raised
Atomic AI is a biotechnology company specializing in the development of a platform for RNA drug discovery.
2
Funding Rounds
$42.0m
Money raised
ScienceIO is a Boston-based company developing an artificial intelligence-powered evidence exploration and synthesis platform.
2
Funding Rounds
$8.0m
Money raised
Orexigen Therapeutics is a biopharmaceutical company developing treatments for obesity founded in 2002 by Eckard Weber.
3
Funding Rounds
$76.0m
Money raised
A virtual assistant in Italy that focuses on improving people's quality of life and supporting the process of developing innovative and personalized drugs.
1
Funding Rounds
$2.2m
Money raised
A company using metabolic engineering and synthetic biology to produce biochemicals from renewable feedstocks.
3
Funding Rounds
$18.4m
Money raised
Coral is a biotechnology company, founded in 2018, that creates large datasets which represent the diversity of human biology to improve development and deployment of drugs and make clinical trials more efficient through predicting patient responses to drugs.
3
Funding Rounds
$5.7m
Money raised
Targazyme is a biotechnology company focused on improving survival and quality of life for cancer patients using stem cell transplantation, immunotherapy, regenerative medicine, and gene therapy.
1
Funding Rounds
$2.5m
Money raised
A biotechnology company discovering drugs that target the epitranscriptomics machinery that modifies RNA.
1
Funding Rounds
$54.0m
Money raised
A proteomics-based diagnostics company providing research services for the development of personalized medicine
6
Funding Rounds
$5.1m
Money raised
Trialspark is a company founded in 2013 by Benjamine Liu, kit dobyns and linhao zhang.
3
Funding Rounds
$156.0m
Money raised
Aiforia is a Helsinki-based artificial intelligence company developing image analysis technology for diagnostics.
6
Funding Rounds
$76.9m
Money raised
Datavant is a San Francisco-based company founded in 2017.
2
Funding Rounds
$80.0m
Money raised
Entos Pharmaceuticals develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system.
1
Funding Rounds
Immunobiochem is a biotechnology company that is committed to addressing unmet medical need in oncology via research and development of novel, targeted biological therapeutics.
2
Funding Rounds
Unlearn is a San Francisco, California-company developing artificial intelligence tools and software for medical research.
5
Funding Rounds
$69.9m
Money raised
NemaMetrix is a drug discovery company founded in 2011 by Matt Beaudet.
9
Funding Rounds
$15.9m
Money raised
Phenomic AI is a Toronto-based company.
4
Funding Rounds
$8.0m
Money raised
celldom is a single cell omics company founded in 2016 by Zach Forbes, Benjamin Yellen and Kris Wood.
4
Funding Rounds
$2.0m
Money raised
Glympse Bio is developing a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases.
5
Funding Rounds
$94.3m
Money raised
Ionpath is a Menlo Park, California-based medical diagnostic tool company.
3
Funding Rounds
$18.0m
Money raised
A company developing treatments for cancer and autoimmune diseases
3
Funding Rounds
$13.5m
Money raised
A company making voice recognition products capable of detecting cognitive decline and cognitive impairment based on samples of speech.
1
Funding Rounds
$4.2m
Money raised
Expansion Therapeutics is a RNA Targeted Small Molecules founded in 2016.
2
Funding Rounds
$135.3m
Money raised
AstronauTx is a London-based biotechnology research company developing treatments for neurogenerative diseases.
6
Funding Rounds
$195.8m
Money raised
Qynapse provides an FDA-Cleared neuroimaging software platform.
1
Funding Rounds
$2.8m
Money raised
ValiRx PLC. is a Cambridge, Massachusetts-based healthcare accelerator working to develop new medicines and technologies founded in 2000.
1
Funding Rounds
$1.2m
Money raised
A biotechnology company developing targeted cell-based immunotherapies for the treatment of cancer
1
Funding Rounds
$2.0m
Money raised
Microdermics is a skincare company founded in 2014 by Grant Campany, Boris Stoeber, Sahan Ranamukhaarachchi and Iman Mansoor.
2
Funding Rounds
$1.5m
Money raised
A company developing drugs that halt tumor growth and disrupt metastasis
1
Funding Rounds
$7.2m
Money raised
KPI Therapeutics is a company that focuses on developing potentially game changing autoimmune therapies.
3
Funding Rounds
$27.0k
Money raised
BioMotiv is a company focused on advancng therapeutics development founded in 2012.
1
Funding Rounds
$21.0m
Money raised
Developer of ADCs to treat metastatic solid tumors.
2
Funding Rounds
$21.3m
Money raised
GERO is a small Molecules founded in 2015 by Maxim Kholin.
2
Funding Rounds
$4.4m
Money raised
Deep Intelligent Pharma is a drug researching company with focus in artificial intelligence.
2
Funding Rounds
$6.6m
Money raised
Dalriada Therapeutics is a Mississauga-based research and development company offering a diagnostics and drug discovery platform.
1
Funding Rounds